Evidence map›Paper›PMID 24799258›Full record

ArticleObesity (Silver Spring, Md.)2014

Reversible hyperphagia and obesity in rats with gastric bypass by central MC3/4R blockade.

Michael B Mumphrey, Zheng Hao, R Leigh Townsend, Laurel M Patterson, Christopher D Morrison, Heike Münzberg, Nicholas Stylopoulos, Jianping Ye, Hans-Rudolf Berthoud

Open access · bronzeAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Does gastric bypass surgery change body weight set point?International journal of obesity supplements · 2016
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. The physiology underlying Roux-en-Y gastric bypass: a status report.American journal of physiology. Regulatory, integrative and comparative physiology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Michael B MumphreyPennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, 70808, USA.
Zheng Hao
R Leigh Townsend
Laurel M Patterson
Christopher D Morrison
Heike Münzberg
Nicholas Stylopoulos
Jianping Ye
Hans-Rudolf Berthoud
Louisiana State University System · USPennington Biomedical Research Center · USBoston Children's Hospital · US

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI ROBERT A KESTERSON · 2005 to 2026
$26.5M
Neural mechanisms controlling food intake and body weight after bariatric surgeryR01DK047348 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI BERTHOUD, HANS-RUDOLF · 1994 to 2018
$5.0M
Mechanism of IKK in FFA-associated Insulin ResistanceR01DK068036 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI YE, JIANPING · 2004 to 2013
$2.7M
Adipose Tissue Hypoxia and Inflammation in ObesityR01DK085495 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI YE, JIANPING · 2010 to 2013
$1.3M
NIDDK NIH HHS DK047348NIDDK NIH HHS DK072476NIDDK NIH HHS DK086036NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK047348NIDDK NIH HHS R01 DK068036NIDDK NIH HHS R01 DK085495
6 · The paper itself

Abstract

objectiveTo test the commonly held assumption that gastric bypass surgery lowers body weight because it limits the ability to eat large amounts of food.

methodsCentral melanocortin signaling was blocked by ICV infusion of the melanocortin-3/4 receptor antagonist SHU9119 for 14 days in rats whose high-fat diet-induced obesity had been reversed by Roux-en-Y gastric bypass surgery.

resultsSHU9119 increased daily food intake (+ 100%), body weight (+30%), and fat mass (+50%) in rats with RYGB, surpassing the presurgical body weight and that of saline-treated sham-operated rats. Doubling of food intake was entirely due to increased meal frequency, but not meal size. After termination of SHU9119, body weight promptly returned to near preinfusion levels. In sham-operated rats, SHU9119 produced even larger increases in food intake and body weight.

conclusionsRYGB rats do not settle at a lower level of body weight because they cannot eat more food as they can easily double food intake by increasing meal frequency. The reversible obesity suggests that RYGB rats actively defend the lower body weight. However, because both RYGB and sham-operated rats responded to SHU9119, central melanocortin signaling is not the critical mechanism in RYGB rats responsible for this defense.

Indexed as

Gastric BypassHyperphagiaWeight LossAnimalsBody WeightDiet, High-FatEatingMaleMelanocortinsMelanocyte-Stimulating HormonesObesityRatsRats, Sprague-DawleyReceptor, Melanocortin, Type 4MelanocortinsMelanocyte-Stimulating HormonesReceptor, Melanocortin, Type 4SHU 9119

Identifiers

PMID24799258
PMCPMC4114988
OpenAlexW1498516204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.